image

Authoritative Independent Monthly Share Selections Using Technical & Fundamental Analysis

Latest issue now available

UDG Healthcare

February 2017

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

  • Epic Code:
  • UDG
  • Price:
  • 662p
The shares registered an all-time high of 689p on 8th December and remain c. £1 ahead of our tip price just over a year ago. Full year results showed underlying revenue and profit up 7% and 9% respectively to Eu 943m and Eu 104.2m and came in spite of a year of reorganisation following the disposal of its legacy wholesale drug supply business and two acquisitions at Ashfield, one of its two bright new divisions.Ashfield’s biggest part is contract sales outsourcing (CSO), whereby its own sales force effectively takes over a healthcare / pharmaceutical firm’s sales and marketing functions, plugging in to the trend for Big Pharma to cut costs, given pressure on their portfolios from patent expiries and generic compet ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X